Plant Design Critical in Sterile Manufacturing, Expert Says
Rebuilding 'problem' sterile manufacturing plants to modern specifications may be a better option than spending money trying to fix them according to an ex-GSK expert.
Rebuilding 'problem' sterile manufacturing plants to modern specifications may be a better option than spending money trying to fix them according to an ex-GSK expert.
Ernst & Young (E&Y) analysts will try to illuminate the Sunshine Act for Greenphire's customers in the third collaboration the trial payment technology firm has signed in as many weeks.
Intertek has acquired Melbourn Scientific, citing its capabilities in delivery device testing and formulation services as the key drivers for the deal.
US scientists claim their combination of a novel nanoparticle production platform and innovative spray coating technology paves the way for improved drug, biologic and vaccine targeting.
BD has invested €3.5m ($4.5m) at a syringe manufacturing facility in Ireland, creating 28 new jobs.